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The most widely recognized property of the HIV-1 Vpr
auxiliary protein is its ability to arrest cell cycle progres-
sion at the G2 phase, which eventually triggers an apop-
totic response. There is a long standing controversy as to
whether Vpr might exhibit cytopathic activity independ-
ently of its G2 arrest property.
We developed a clonogenic assay based on the expression
of wild-type and mutant versions of Vpr using an EBV-
based episome carrying a hygromycin resistance selection
marker. Expression of the wt Vpr protein abrogated the
formation of hygromycin-resistant cell colonies, confirm-
ing that long-term expression of Vpr is lethal in dividing
cells. We previously showed that Vpr promotes G2 arrest
through the recruitment of the DCAF1 adaptor of the
Cul4A ubiquitin ligase. Intriguingly, several HIV-1 Vpr
mutants, which are devoid of G2 arrest properties but con-
serve DCAF1 binding, strongly reduced the formation of
hygromycin-resistant cell colonies. Long term expression
of these mutants induced G1 arrest and apoptosis. Thus
Vpr expression can cause cell death independently of its
G2 arrest activity.
Disruption of the DCAF1-binding function of Vpr
restored efficiency of colony formation indicating that
recruitment of DCAF1 is required for this second cytotoxic
activity of Vpr. However, DCAF1 binding is not sufficient
to confer cytopathicity since Vpx from HIV-2/SIVsm does
not impair colony formation.
Altogether our data indicate that Vpr exhibits two dictinct
cytotoxic activities in dividing cells, which both require
the recruitment of DCAF1. Based on the current view of
Vpr mechanism of action, i.e. hijacking of the host ubiq-
uitination machinery, Vpr likely induces the proteasome-
mediated degradation of two host proteins which are
independently required for proper cell growth. This work
was supported by grants from ANRS, Sidaction, Fondation
de France and Mairie de Paris.
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